OPRX: Rasio silihan jangka dawa marang modal optimizerx.com

Lambang korporat lan logo OptimizeRx Inc. (OPRX)

The OptimizeRx Corporation (OPRX) digital ecosystem connects drug manufacturers with healthcare providers, optimizing drug distribution and marketing ROI. The market price trend reflects a value of 0.13. High switching costs and network effects strengthen the company's position, while integration into electronic health records creates a robust economic moat. Strict HIPAA regulations and exclusive agreements with pharmaceutical companies limit market entry for new competitors.

OptimizeRx Corp. (OPRX) - Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 29.10.2026
Produk asli OptimizeRx Corp

This ratio measures the proportion of long-term liabilities within the equity structure, allowing for an assessment of financial stability and the company's degree of dependence on external debt financing. By analyzing the long-term debt-to-equity ratio, an investor can determine how effectively OptimizeRx Corporation (OPRX) utilizes credit resources to scale its B2B platform while maintaining a high level of industry confidence.

Analisis perusahaan pesaing

Veeva Systems (VEEV) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio silihan jangka dawa marang modal HQY|Waystar Holding Corp. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRVL|PRVA - Utang jangka dawa marang ekuitas|Huron Consulting Group Inc. (HURN) - Rasio utang jangka dawa marang ekuitas|CERT: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Omnicell Health (OMCL)|GDRX (GoodRx Holdings, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal SDGR (schrodinger.com)|Utang jangka dawa marang ekuitas Phreesia (PHR)|OMDA - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Evolent EVH|HSTM (HealthStream Learning) - Kewajiban jangka dawa marang ekuitas|DH: Rasio utang jangka dawa marang ekuitas|consensus.com - Rasio silihan jangka dawa marang modal|AGL: Utang jangka dawa marang modal|ABSI - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas SoYoung|Rasio utang jangka dawa marang ekuitas nrchealth.com (NRC)|Utang jangka dawa marang modal SPOK|Rasio tanggungan utang jangka dawa marang modal trubridge.com|Simulations Plus - Rasio utang jangka dawa marang ekuitas|SOPH (Sophia Genetics) - Kewajiban jangka dawa marang ekuitas|Health Catalyst, Inc - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal CareCloud, Inc.|Research Solutions (RSSS) - Utang jangka dawa marang ekuitas|DLH Holdings - Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas ONMD|Rasio utang jangka dawa marang modal SCNX (Scienture Holdings)|Rasio utang jangka dawa marang ekuitas HCTI (Healthcare Triangle Corp)|ISPC (ispecimen.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal BFRG (Bullfrog AI)|WORX - Rasio utang jangka dawa marang ekuitas|MSPR - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal iCoreConnect Inc.|TRxADE (MEDS) - Utang jangka dawa marang ekuitas|Orgenesis Corporation - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas R1 RCM, Inc.|sharecare.com - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Streamline Health (STRM)|SYRA - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Apollo Medical Holdings, Inc. AMEH|Koefisien utang jangka dawa marang modal MODN|NextGen Healthcare - Utang jangka dawa marang modal